13F filer · CIK 872589
REGENERON PHARMACEUTICALS, INC.
TARRYTOWN, NY · filing since Q4 2024 · last filing Nov 5, 2026
Reported value
$179.6M
+$2.4M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%
Biggest buys vs Q2 2026
No new or increased positions this quarter.
Biggest sells vs Q2 2026
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Parabilis Medicines, Inc.COMMON STOCK | 4,166,666 | $134.5M | 74.90% |
| 2 | Intellia Therapeutics, Inc.COMMON STOCK | 3,702,995 | $44.7M | 24.86% |
| 3 | Adicet Bio, Inc.COMMON STOCK | 60,511 | $432.0K | 0.24% |